DragOnFlow Systems
Real-time clinical trial workflow
Company Overview
Snapshot
Founded in March 2022 by Sarid Smadar, David Ron, and Nahi Nachmani, DragOnFlow Systems operates with 1–10 employees. The company has secured funding across one round, with GSD Venture Studio participating in its Seed round in December 2022.
Business overview
DragOnFlow Systems develops a real-time clinical trial workflow platform designed to automate and streamline clinical research processes. Its core technology transforms traditional paper-based and repository electronic tools into an interactive, point-of-care execution system. The company aims to bridge the gap between protocol design and site-level implementation, serving the health tech and life sciences sectors by reducing errors, improving compliance, and accelerating timelines in clinical trials.
Company Intelligence Q&A
- When was DragOnFlow Systems founded?
- DragOnFlow Systems was founded in March 2022.
- Who are the founders of DragOnFlow Systems?
- The founders of DragOnFlow Systems are Sarid Smadar, David Ron, and Nahi Nachmani.
- What is DragOnFlow Systems' primary sector?
- DragOnFlow Systems' primary sector is Health Tech & Life Sciences.
- What is DragOnFlow Systems' core product?
- DragOnFlow Systems offers a product named DragOnFlow, which automates the investigator’s workflow in clinical trials, handling logic, calculations, assessments, dosing, compliance, and documentation in real time.
- Which investor participated in DragOnFlow Systems' Seed round?
- In December 2022, GSD Venture Studio participated in DragOnFlow Systems' Seed funding round.